Boehringer Ingelheim: Colorectal Neoplasms trials
The registry lists 14 Colorectal Neoplasms studies with Boehringer Ingelheim as lead sponsor. 1 are open to participants now and 6 have results posted.
Phase 1 6Phase 2 6Phase 3 2No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has SpreadRecruitingNCT06324357Phase 1/2
- A Study in People With Colorectal Cancer to Test Whether Ezabenlimab or Pembrolizumab in Combination With BI 765063 Lead to Side Effects or Delays in SurgeryTerminatedNCT05446129Phase 1Results posted
- Nintedanib Alone or in Combination With Capecitabine in Refractory Metastatic Colorectal Cancer [LUME-Colon 2]TerminatedNCT02780700Phase 2Results posted
- Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal CancerCompletedNCT02776683Phase 3Results posted
- Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1)CompletedNCT02149108Phase 3Results posted
- A Study of BIBW 2992 (Afatinib) in Patients With Metastatic Colorectal CancerCompletedNCT01152437Phase 2Results posted
- BIBF 1120 Versus Bevacizumab in Metastatic Colorectal CancerCompletedNCT00904839Phase 2Results posted
- A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or PancreasTerminatedNCT06882746Phase 1
- A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6TerminatedNCT06091930Phase 1
- A Study to Compare Tissue and Liquid Biopsies in People With Different Types of CancerActive, not recruitingNCT05708599Not applicable
- A Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With Ezabenlimab to Patients With Advanced Solid Tumors Expressing the Protein B7-H6 on the Cell SurfaceCompletedNCT04752215Phase 1
- A Study to Test Different Doses of BI 1701963 in Combination With Irinotecan in People With Advanced Bowel Cancer With Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) MutationTerminatedNCT04627142Phase 1
- Intravenous BIBH 1 in Patients With Metastatic Colorectal CancerCompletedNCT02198274Phase 2
- A Phase II Trial of Weekly Alternating Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Advanced Colorectal CancerCompletedNCT00801294Phase 2